11-β hydroxysteroid dehydrogenase type 2 expression in white adipose tissue is strongly correlated with adiposity

被引：37

作者：

Milagro, Fermin I. ^{[1
]}

Campion, Javier ^{[1
]}

Martinez, J. Alfredo ^{[1
]}

机构：

[1] Univ Navarra, Dept Physiol & Nutr, Pamplona 31008, Spain

来源：

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 2007年 / 104卷 / 1-2期

关键词：

hydroxysteroid 11-beta dehydrogenase type 2; obesity; high-fat diet; RT-PCR; glucocorticoid receptor; leptin; insulin resistance;

D O I：

10.1016/j.jsbmb.2006.10.006

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Glucocorticoid action within the cells is regulated by the levels of glucocorticoid receptor (GR) expression and two enzymes, 11-beta hydroxysteroid dehydrogenase type 1 (11 beta HSD1), which converts inactive to active glucocorticoids, and 11-beta hydroxysteroid dehydrogenase type 2 (11 beta HSD2), which regulates the access of active glucocorticoids to the receptor by converting cortisol/corticosterone to the glucocorticoid-inactive form cortisone/dehydrocorticosterone. Male Wistar rats developed obesity by being fed a high-fat diet for 56 days, and GR, 11 beta HSD1 and 11 beta HSD2 gene expression were compared with control-diet fed animals. Gene expression analysis of 11 beta HSD1, 11 beta HSD2 and GR were performed by RT-PCR in subcutaneous and retroperitoneal adipose tissue. High-fat fed animals overexpressed 11 beta HSD2 in subcutaneous but not in retroperitoneal fat. Interestingly, mRNA levels strongly correlated in both tissues with different parameters related to obesity, such as body weight, adiposity and insulin resistance, suggesting that this gene is a reliable marker of adiposity in this rat model of obesity. Thus, 11 beta HSD2 is expressed in adipose tissue by both adipocytes and stromal-vascular cells, which suggests that this enzyme may play an important role in preventing fat accumulation in adipose tissue. (C) 2006 Elsevier Ltd. All rights reserved.

引用

页码：81 / 84

页数：4

共 16 条

[1] Differentiation of adipose stromal cells:: The roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase [J].

Bujalska, IJ ;

Kumar, S ;

Hewison, M ;

Stewart, PM .

ENDOCRINOLOGY, 1999, 140 (07) :3188-3196

[2] Does central obesity reflect ''Cushing's disease of the omentum''? [J].

Bujalska, IJ ;

Kumar, S ;

Stewart, PM .

LANCET, 1997, 349 (9060) :1210-1213

[3] Ketoconazole, an antifungal agent, protects against adiposity induced by a cafeteria diet [J].

Campión, J ;

Martínez, JA .

HORMONE AND METABOLIC RESEARCH, 2004, 36 (07) :485-491

[4] 11β-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action [J].

Draper, N ;

Stewart, PM .

JOURNAL OF ENDOCRINOLOGY, 2005, 186 (02) :251-271

[5] Regulation of 11β-HSD genes in human adipose tissue:: Influence of central obesity and weight loss [J].

Engeli, S ;

Böhnke, J ;

Feldpausch, M ;

Gorzelniak, K ;

Heintze, U ;

Janke, J ;

Luft, FC ;

Sharma, AM .

OBESITY RESEARCH, 2004, 12 (01) :9-17

[6] Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11β-hydromysteroid dehydrogenase [J].

Hadoke, PWF ;

Christy, C ;

Kotelevtsev, YV ;

Williams, BC ;

Kenyon, CJ ;

Seckl, JR ;

Mullins, JJ ;

Walker, BR .

CIRCULATION, 2001, 104 (23) :2832-2837

[7] Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity [J].

Kershaw, EE ;

Morton, NM ;

Dhillon, H ;

Ramage, L ;

Seckl, JR ;

Flier, JS .

DIABETES, 2005, 54 (04) :1023-1031

[8] Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2 [J].

Kotelevtsev, Y ;

Brown, RW ;

Fleming, S ;

Kenyon, C ;

Edwards, CRW ;

Seckl, JR ;

Mullins, AJ .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05) :683-689

[9]

Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560

[10] A transgenic model of visceral obesity and the metabolic syndrome [J].

Masuzaki, H ;

Paterson, J ;

Shinyama, H ;

Morton, NM ;

Mullins, JJ ;

Seckl, JR ;

Flier, JS .

SCIENCE, 2001, 294 (5549) :2166-2170

← 1 2 →